Duke-NUS Medical School (Duke-NUS) in Singapore and IPGaia, Inc. (IPG) in Japan have signed an agreement to jointly adva...
Japan-headquartered Global Health Innovative Technology Fund (GHIT Fund) and Switzerland-based Medicines Patent Pool (MP...
Japan based Shionogi and US based Apnimed, Inc. have agreed to establish a joint venture (JV) company, Shionogi-Apnimed ...
I Peace, Inc., specialising in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies based in Palo Alto...
Japan-headquartered pharmaceutical company Daiichi Sankyo's Board has passed a resolution on the basic policy for ...
US-based startup AnHeart Therapeutics has entered into an exclusive license agreement with Nippon Kayaku to market ...
Japan-based companies Sumitomo Pharma and AlphaNavi Pharma have announced that AlphaNavi has exercised its option rights...
Debiopharm International SA, Yakult Honsha and Takata Pharmaceutical have agreed that Yakult Honsha will transfer ...
Mithra Biotech, a company dedicated to women’s health, has announced that its licence holder Fuji Pharma has submi...
Japan-headquartered firm Shimadzu Corporation has launched the “Urina” integrated management type urine volu...
Japanese pharmaceutical firm Daiichi Sankyo and US-based life sciences company Merck (known as MSD outside of the United...
Japan-based companies Fujitsu and TOPPAN Holdings Inc. have concluded a business alliance agreement to jointly promote t...
British medtech company Smith+Nephew has announce the launch of its REGENETEN Bioinductive Implant allowing access to th...
The Global Health Innovative Technology Fund (GHIT Fund), headquartered in Japan, and the Institut Pasteur de Dakar (IPD...
Astellas Pharma, BioLabs Global and Mitsui Fudosan have agreed on a tri-party Memorandum of Understanding to e...
Singapore's National University Hospital (NUH) and the Yong Loo Lin School of Medicine at the National University of Sin...
Fujitsu Limited and the High Performance Computing (HPC)- and AI-driven Drug Development Platform Division of the RIKEN ...
US-based Lokavant, the clinical trial intelligence platform company, has announced an $8 million strategic investment fr...
